- Investing Ideas
- /
- Swedish Healthcare Undervalued over 20% based on DCF
Swedish Healthcare Undervalued over 20% based on DCF
UPDATED May 03, 2024
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
13 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
GETI B | kr232.30 | -1.2% | -8.1% | kr63.3b | kr235.50 | PE27.7x | E13.2% | 1.9% | ||
EKTA B | kr76.95 | 1.8% | -12.6% | kr29.4b | kr83.42 | PE20.5x | E14.5% | 3.1% | ||
VIMIAN | kr31.40 | 6.8% | -15.1% | kr16.4b | kr38.97 | PE177.5x | E61.6% | n/a | ||
XVIVO | kr378.00 | 1.3% | 23.5% | kr11.9b | kr408.00 | PE118.6x | E36.1% | n/a | ||
CEVI | kr226.50 | 2.7% | 22.0% | kr5.4b | kr257.50 | PE38.3x | E23.6% | 1.0% | ||
RAY B | kr118.40 | 1.2% | 59.1% | kr4.1b | kr135.00 | PE49.8x | E34.7% | 0.6% | ||
BACTI B | kr72.00 | 4.7% | -1.9% | kr2.5b | kr80.00 | PS12.5x | E71.3% | n/a | ||
EQL | kr44.80 | 3.5% | 30.2% | kr1.3b | kr48.00 | PE58.8x | E47.4% | n/a | ||
SYNT | kr27.70 | 0% | -13.4% | kr1.2b | kr30.00 | PE115.3x | E47.4% | 0% | ||
INTEG B | kr55.40 | -0.4% | 121.6% | kr1.0b | kr70.75 | PS10.2x | E70.4% | n/a | ||
SEZI | kr7.34 | 7.6% | 30.4% | kr878.6m | kr13.50 | PS24.6x | E73.6% | n/a | ||
CARE | kr29.00 | 7.4% | 81.3% | kr705.5m | kr28.50 | PE15.4x | E16.8% | n/a | ||
BOUL | kr10.00 | 2.0% | -17.2% | kr388.3m | kr10.40 | PE15.5x | E23.9% | 0% |
Page 1 of 1